3 questions for… Dr. med. Carl-Heinz Müller, Board Member of the National Association of Statutory Health Insurance Physicians (KBV)
DÄ: What use are GPs and patients? In KBV survey last year, 75 percent of the participating patients stated that their treatment had not changed. Müller: First of all, I want to make it clear that family doctors have always treated their patients well. The medical quality is right. General practitioner contracts are primarily about structural issues: treatment pathways and the interfaces between general practitioner, specialist and hospital. With the family doctor as guide who leads the patient through the jungle of the healthcare system, positive effects can be achieved here. After all, our survey also showed that 56 percent of people would like better collaboration between general practitioners and specialists. DÄ: When do selective contracts make sense? And how can the KVen participate? Müller: Selective contracts make sense if you want to try out new treatment paths, for example for certain indications. If they are successful, they should be transferred to standard care. The KBV has developed models in its authorized workshop and has now concluded two general practitioner contracts and one for integrated care for ADHD. If one were to include the KVen as partner or service provider in the selective contracts, their processing, for example in terms of billing, could be enormously simplified. DÄ: Many family doctors hope that the family doctor contracts according to 73 b will provide way out of the fee discomfort and bureaucracy. Why is this path still dangerous from your point of view? Müller: On the one hand, there is risk of patchwork of contracts that would even increase the costs and bureaucracy for the doctors. On the other hand, colleagues should ask themselves whether they really want the security order to go to the cash registers. They then decide who is still allowed to take part in medical care and who is not. We, the KVen and the KBV, have to ensure that the doctors see the collective agreement again as an opportunity with considerable development potential, especially against the background of the shift of morbidity to the health insurance companies.